{"id":"W4377969339","doi":"10.1016/j.kint.2023.05.009","title":"Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","year":2023,"lang":"en","type":"review","venue":"Kidney International","topic":"Erythropoietin and Anemia Treatment","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; Seven Oaks General Hospital","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Akebia Therapeutics; Astellas Pharma; Torii Pharmaceutical; Mitsubishi Tanabe Pharma Corporation; Fresenius Medical Care North America; AstraZeneca; GlaxoSmithKline; Amgen; U.S. Department of Veterans Affairs","keywords":"Medicine; Kidney disease; Anemia; Intensive care medicine; Guideline; Disease; Adverse effect; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001781425,0.0009844331,0.002072945,0.0003194925,0.0001760556,0.0001890755,0.0007563489,0.0003528197,0.002944318],"category_scores_gemma":[0.004524668,0.0007750959,0.00103603,0.000358098,0.0003409473,0.0001981324,0.0005822091,0.0006565626,0.0004347826],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003650801,"about_ca_system_score_gemma":0.01340584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001127217,"about_ca_topic_score_gemma":0.00007769535,"domain_scores_codex":[0.9957986,0.0001150192,0.001137956,0.001168411,0.001103926,0.0006760648],"domain_scores_gemma":[0.9951841,0.0005564659,0.0005712259,0.0007712464,0.0002434831,0.00267349],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001164276,0.003907884,0.05155326,0.04572268,0.01399594,0.00496592,0.0009548119,0.000007000544,0.0001454591,0.02414944,0.5998787,0.2535546],"study_design_scores_gemma":[0.005751692,0.00007552246,0.003285056,0.03380861,0.002154051,0.00002533889,0.00009253372,0.0002518846,8.87395e-7,0.0003407676,0.9535013,0.0007123081],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0000603728,0.8762698,0.0002240328,0.04975709,0.003684465,0.002593493,0.06458989,0.0004940802,0.002326728],"genre_scores_gemma":[0.0006747508,0.956238,0.0006851757,0.006158497,0.001219391,0.0005348353,0.02631077,0.0001385871,0.008039956],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3536226,"threshold_uncertainty_score":0.99947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04415841328740496,"score_gpt":0.3536618694551403,"score_spread":0.3095034561677354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}